Epogin


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 43.8%
Hypertension 16.7%
Nephrogenic Anaemia 13.5%
Duodenal Ulcer 8.3%
Hyperphosphataemia 7.3%
Angina Pectoris 6.3%
Cough 2.1%
Anaemia 1.0%
Bronchopulmonary Aspergillosis 1.0%
Toxic Epidermal Necrolysis 29.4%
Hypertension 17.6%
Leukaemia 17.6%
Blood Creatinine Increased 11.8%
Atrial Fibrillation 5.9%
Cerebral Haemorrhage 5.9%
Dysarthria 5.9%
Pericardial Effusion 5.9%
Concomitant
Product Used For Unknown Indication 33.7%
Hypertension 12.1%
Hyperphosphataemia 10.2%
Drug Use For Unknown Indication 6.0%
Nephrogenic Anaemia 3.8%
Dialysis 3.5%
Procedural Hypotension 3.2%
Insomnia 2.6%
Arteriosclerosis Obliterans 2.5%
Diabetes Mellitus 2.4%
Localised Infection 2.3%
Anaemia 2.3%
Arthralgia 2.2%
Renal Failure Chronic 2.2%
Hyperparathyroidism Secondary 2.1%
Prophylaxis 2.1%
Ill-defined Disorder 1.9%
Hyperlipidaemia 1.7%
Angina Pectoris 1.6%
Constipation 1.6%
Arteriosclerosis Obliterans 12.8%
Anaemia 11.6%
Renal Impairment 8.5%
White Blood Cell Count Decreased 8.5%
Urinary Tract Infection 6.7%
Renal Failure 6.1%
Sudden Death 4.9%
Hypotension 4.3%
Pneumonia 4.3%
Renal Failure Chronic 4.3%
Cardiac Failure 3.7%
Shunt Malfunction 3.7%
Platelet Count Decreased 3.0%
Upper Respiratory Tract Inflammation 3.0%
Gastric Ulcer 2.4%
Infection 2.4%
Liver Disorder 2.4%
Myelodysplastic Syndrome 2.4%
Nausea 2.4%
Neutrophil Count Decreased 2.4%

Drug Data